Stage IV Pancreatic Cancer AJCC v8 Clinical Trials in Portland, Oregon

6 studies are recruiting for stage iv pancreatic cancer ajcc v8 in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Targeted Pathway Inhibition in Patients With Pancreatic Cancer

   This early phase I trial aims to determine how cobimetinib, olaparib, onvansertib, azenosertib, AZD5305 or tremelimumab works in patients with pancreatic cancer. Validation of cobimetinib, olaparib, onvansertib azenosertib, AZD5305 and tremelimumab molecular targets will be explored by comparing pr…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT04005690 on ClinicalTrials.gov

2. Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

   This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial 4-8 months of chemotherapy. Usual care options include additional chemotherapy, observation, or sta…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Oregon Health and Science University, Portland, Oregon

   Locations

   333 in total

   Run by

   NRG Oncology

   See if you can join NCT06958328 on ClinicalTrials.gov

3. Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

   This phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil [5-FU] or irinotecan, leucovorin, and 5-FU or nab-paclitaxel and gemcitabine) versus standard chemotherapy alone in treating patients with KRAS wild…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Providence Portland Medical Center, Portland, Oregon

   Locations

   274 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT06998940 on ClinicalTrials.gov

4. OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

   This early phase I trial studies the biological activity of OMO-103 in patients with pancreatic ductal adenocarcinoma that has spread to nearby tissue or lymph nodes (locally advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). OMO-103 ma…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT07089940 on ClinicalTrials.gov

5. A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

   This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the bod…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Ohio State University-Telemedicine, Portland, Oregon

   Locations

   109 in total

   Run by

   Sameek Roychowdhury

   See if you can join NCT06906562 on ClinicalTrials.gov

6. LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

   This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is stage IV. Patients with these cancer types are at risk for d…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Providence Portland Medical Center, Portland, Oregon

   Locations

   225 in total

   Run by

   University of Rochester

   See if you can join NCT06073431 on ClinicalTrials.gov